Baseline Interleukin-10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease-Modifying Antirheumatic Drug Naive and Anti-Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis. [PDF]
Liu J +14 more
europepmc +1 more source
Novel pathogenic <i>CTLA4</i> missense variant associated with autoimmune enteropathy and systemic immune dysregulation. [PDF]
Zheng D +11 more
europepmc +1 more source
Autosomal recessive human CTLA-4 deficiency with autoimmune infiltration. [PDF]
Su HC.
europepmc +1 more source
Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer. [PDF]
Xicluna R +14 more
europepmc +1 more source
Adult-Onset LRBA Deficiency Presenting with Rheumatoid Arthritis-Like Manifestations: A Case Report. [PDF]
Ninagawa K +4 more
europepmc +1 more source
Real-world association of biologic and targeted synthetic DMARD use with mortality in rheumatoid arthritis-associated interstitial lung disease: a nationwide cohort study. [PDF]
Joo YB +5 more
europepmc +1 more source
Correction to "A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis". [PDF]
europepmc +1 more source
Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis. [PDF]
Contreras G +8 more
europepmc +1 more source
Real-World Effectiveness of Biologic and Targeted Synthetic Therapies in Rheumatoid Arthritis: a Multicenter Study from Rheumatoid Arthritis Saudi Database (RASD). [PDF]
Almoallim HM +14 more
europepmc +1 more source

